Newsroom
Study Shows TruGraf Blood Test Enables Non-invasive Detection of Immune Quiescent Kidney Transplant Recipients
Mansfield, MA, October 24, 2017 — Transplant Genomics Inc. (TGI), a molecular diagnostics company committed to improving organ transplant outcomes, announces…
U.S. patent issues for gene expression profiles associated with chronic kidney allograft rejection, licensed exclusively to Transplant Genomics Inc.
Mansfield, MA, September, 2017 — The Scripps Research Institute (TSRI) has been issued a patent (US 9,752,191) covering gene expression profiles…
Genomic Signature for Predicting Acute Rejection in Liver Transplant Patients to be Presented at the American Transplant Congress
Chicago, IL, May 1, 2017— Dr. Josh Levitsky, Professor of Medicine (Gastroenterology, Hepatology) and Surgery (Organ Transplantation) at Northwestern University Feinberg School…
Transplant Genomics enters collaboration with Mayo Clinic
ROCHESTER, Minn. — Transplant Genomics Inc.® (TGI) is collaborating with the Mayo Clinic Center for Individualized Medicine to develop, validate and commercialize diagnostic tests…
Transplant Genomics Announces Immunosuppressive Clinical Trials Collaboration with Astellas Pharmaceuticals
Pleasanton, CA, and San Francisco, CA, May 2, 2016 — Transplant Genomics® today announced that they have signed a laboratory services agreement…
Transplant Genomics® and Quark Pharmaceuticals Announce Discovery and Development Collaboration
Pleasanton, CA, and San Francisco, CA, April 14, 2016 – Transplant Genomics Inc. (“TGI”) and Quark Pharmaceuticals, Inc. (“Quark”) today announced…
Transplant Genomics Announces Expansion of Scientific Advisory Board
Brookline, MA, January 11, 2016 — Transplant Genomics Inc. (TGI) is a molecular diagnostics company committed to improving kidney transplant outcomes…
Transplant Genomics Announces First Four Transplant Centers Participating in TruGraf Early Access Program
Brookline, MA, December 17, 2015 — Brookline, MA, December 17, 2015 – Transplant Genomics Inc. (TGI) is a molecular diagnostics company…
Transplant Genomics Inc. Supports First ASTS Faculty Research Grant for Biomarker Discovery and Functional Genomics
Brookline, MA, May 5, 2015 —The American Society of Transplant Surgeons (ASTS) announced that Qizhi Tang, PhD, of the University of…
Dr. Roy First Joins Transplant Genomics as Chief Medical Officer
Brookline, MA, April 30, 2015 — Transplant Genomics Inc. (TGI) has announced the appointment of Dr. Roy First as its Chief…